Has John Smith, MD received payments from drug or device companies?

Yes. Drug and device makers reported $16,850 in general payments to John Smith, MD across 121 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Smith, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Smith, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Smith, MD

Urology · Winston Salem, NCNPI 1477540466

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (44.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by SWAN Valley Medical Incorporated at 36.2% of the total. Reporting peaked in 2024 at $7,452 and has fallen 82.6% since, to $1,294 in 2025. Among urology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,850in general payments, 2019–2025

Across 121 payments — averaging $139.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

SWAN Valley Medical Incorporated$6K
Medtronic$4K
Coloplast$2K
Axonics, Inc.$2K
Procept Biorobotics Corporation$1K
Uromedica, Incorporated$1K
plus $1K from 9 others

$5,172in research payments, 2019–2025

Across 5 payments — averaging $1034.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Coloplast$4K
AbbVie$852

$0in ownership & investment interests, 2019–2025

Across 3 payments — averaging $0.00 each. An ownership or investment interest held by the physician or an immediate family member.

SWAN Valley Medical Incorporated$0

What the payments were for

Consulting fees$5,00030%
Speaking & faculty fees$1,1527%
Travel & lodging$3,24719%
Food & beverage$7,45144%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
SWAN Valley Medical Incorporated	20	$6,098
Medtronic(2 entities)	22	$3,545
Coloplast	21	$1,857
Axonics, Inc.	22	$1,804
Procept Biorobotics Corporation	12	$1,244
Uromedica, Incorporated	2	$1,000
Dendreon Pharmaceuticals LLC	7	$610
Boston Scientific	6	$333
AbbVie(2 entities)	3	$110
Neotract Inc.	1	$94
AMAG Pharmaceuticals, Inc.	1	$72
Laborie Medical Technologies Corp.	1	$36
Johnson & Johnson	1	$23
Urogen Pharma, Inc.	1	$14
Ambu Inc.	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,850 in reported general payments places this provider in the 90th percentile of 434 urology providers in North Carolina.

See all urology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$152,941

Medicare patients

380

Services billed

6,041

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MyrbetriqMirabegron	128	$84,039
GemtesaVibegron	38	$24,601
PremarinEstrogens, Conjugated	39	$16,850
AvodartDutasteride	12	$13,424
Methenamine Hippurate	123	$6,797
Estradiol	62	$3,551
Trimethoprim	101	$3,385
Solifenacin Succinate	83	$2,343
Cefdinir	193	$2,301
Tolterodine Tartrate ErTolterodine Tartrate	26	$1,557
Tamsulosin Hcl	95	$1,396
Oxybutynin Chloride ErOxybutynin Chloride	113	$1,385
Finasteride	96	$870
Ciprofloxacin Hcl	191	$794
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	43	$745

Paid to pharmacies, not to this prescriber.

Other urology in Winston Salem

Ryan TerleckiWinston Salem$219K
Soroush Rais-BahramiWinston Salem$66K
Ethan MatzWinston Salem$62K
Kyle ScarberryWinston Salem$57K
Connor PolicastroWinston Salem$53K
Colin KleinguetlWinston Salem$52K
Anthony AtalaWinston Salem$26K
Gopal BadlaniWinston Salem$25K
Alejandro RodriguezWinston Salem$17K
Robert LippittSmithfield$11.4M

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →